How were (MGCD)'s earnings last quarter?

(MGCD) (NASDAQ:MGCD) released its earnings results on Wednesday, September, 7th. The medical equipment provider reported $0.06 earnings per share (EPS) for the quarter. The medical equipment provider earned $9.90 million during the quarter, compared to analyst estimates of $9.20 million.

What other stocks do shareholders of (MGCD) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (MGCD) investors own include Allena Pharmaceuticals (ALNA) , Akers Biosciences (AKER) , Ampliphi Biosciences (APHB) , Veru (VERU) , Arbutus Biopharma (ABUS) , Aurora Cannabis (ACBFF) , Achieve Life Sciences (ACHV) , AcelRx Pharmaceuticals (ACRX) , Acacia Research (ACTG) and Achaogen (AKAO) .

NASDAQ:MGCD

(MGCD) (MGCD) Stock Price, News & Analysis

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)

Free MGCD Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Today's Range: $11.03
▼
$11.03
50-Day Range: N/A
52-Week Range: $6.24
▼
$11.20

Volume: N/A
Average Volume: 15,965 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get (MGCD) alerts:

Ad InvestorPlace

You’re invited: Biggest crypto event of 2024

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

About (MGCD)

MGC Diagnostics Corporation is a medical technology company, which offers cardiorespiratory health solutions. The Company designs, markets and sells non-invasive cardiorespiratory diagnostic products. It sells its products internationally through distributors and in the United States through a direct sales force targeting specialists located in hospitals, university-based medical centers, medical clinics, physician offices, pharmaceutical companies, medical device manufacturers and clinical research organizations (CROs). Its cardiorespiratory diagnostic products measure flow and respiratory pressures and, in most cases analyze the inhaled and exhaled gases, such as oxygen and carbon dioxide. Its products include pulmonary function (PFT) and gas exchange (GX) testing products. The Company's pulmonary function products are divided into four product categories: Spirometry, Complete Pulmonary Function, Body Plethysmography and Specialty Products.

Ad InvestorPlace

You’re invited: Biggest crypto event of 2024

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

MGCD Stock News Headlines

January 9, 2024 | msn.com

Sonu Sood’s ‘Fateh’ is a cinematic tribute to cybercrime victims

December 31, 2023 | msn.com

Lakers' LeBron James irate after foot on line discounts potential tying shot in loss to Timberwolves

April 19, 2024 | InvestorPlace (Ad)

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

November 6, 2023 | msn.com

‘Defuse it quickly;’ Police arrest Springfield student who brought gun to football game

April 5, 2023 | reuters.com

Spencer Torkelson knocks in three as Tigers beat Astros

February 11, 2023 | msn.com

Busy Wednesday schedule kept Jenna Ortega from returning to You Season 4

December 29, 2022 | msn.com

Wrexham science discovery centre to launch Monday warm hub drop in sessions

December 17, 2022 | msn.com

F1 News: 2023 Aston Martin AMR23 Reveal Date Announced

April 19, 2024 | InvestorPlace (Ad)

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

October 25, 2022 | msn.com

The Northern Belle train returns to Grantham for rare appearance this Christmas

September 28, 2022 | msn.com

Open Thread: Buffalo Sabres vs. Columbus Blue Jackets (Preseason)

August 18, 2022 | msn.com

L.A. County authorities search for woman, 23, missing since July

See More Headlines

Receive MGCD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (MGCD) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 9/07/2016
Today: 4/18/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: N/A
Industry: N/A
Sub-Industry: N/A
Current Symbol: NASDAQ:MGCD
Previous Symbol: NASDAQ:ANGN
CUSIP: N/A
CIK: 815093
Web: mgcdiagnostics.com
Phone: +1-651-4844874
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

Greg Greenberg
Chairman of the Board
Matthew S. Margolies (Age 50)
President
Todd M. Austin (Age 54)
Chief Executive Officer
Larry Robert Degen (Age 62)
Interim Chief Financial Officer, Chief Accounting Officer, Secretary
Hendrik Struik (Age 49)
Independent Director

MGCD Stock Analysis - Frequently Asked Questions

How were (MGCD)'s earnings last quarter?: (MGCD) (NASDAQ:MGCD) released its earnings results on Wednesday, September, 7th. The medical equipment provider reported $0.06 earnings per share (EPS) for the quarter. The medical equipment provider earned $9.90 million during the quarter, compared to analyst estimates of $9.20 million.
What other stocks do shareholders of (MGCD) own?: Based on aggregate information from My MarketBeat watchlists, some companies that other (MGCD) investors own include Allena Pharmaceuticals (ALNA), Akers Biosciences (AKER), Ampliphi Biosciences (APHB), Veru (VERU), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), Achieve Life Sciences (ACHV), AcelRx Pharmaceuticals (ACRX), Acacia Research (ACTG) and Achaogen (AKAO).

This page (NASDAQ:MGCD) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

(MGCD) (MGCD) Stock Price, News & Analysis

About (MGCD)

MGCD Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

MGCD Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info